mice expressing the full-length human AR containing
). The first detectable phenotype is muscle atrophy of the trunk enhancer and a chicken ␤-actin promoter ( Figure 1A ). We established 3 lines with 24 glutamines (AR-24Q) and and hindlimbs followed by weight loss and impairment of the rotarod task. We detected the onset of motor 5 lines with 97 glutamines (AR-97Q). Copy numbers of the transgene were 1 to 5 in AR-24Q mice and 1 to 3 in impairment by the rotarod task at 8 to 9 weeks of age in the male AR-97Q mice, while 15 weeks or more in the AR-97Q mice (Table 1) . We assessed the 24 or 97 CAG repeat in the transgene by the PCR amplification on females (Table 1 ). The affected mice were hypoactive and dragged their hindlimbs. The forelimbs were not the tail DNA using a fluorescently labeled primer, and subsequent size determination on the polyacrylamide involved until hindlimb atrophy became severe. Males showed a markedly faster and earlier motor deficit than gel did not show unequivocal intergenerational instability in the CAG repeat number (data not shown).
females, and shorter life span. The 50% mortality ranged from 66 to 132 days of age in the male AR-97Q mice of Three of five lines with AR-97Q (#2-6, #4-6, #7-8) exhibited progressive motor impairment, although no 3 lines, whereas mortality of the female AR-97Q mice remained only 10% to 30% at more than 210 days in lines with AR-24Q showed any manifested phenotypes up to the latest age examined, 30 weeks old. All three the 3 lines. The cause of death was cachexia due to hyponutrition and dehydration. symptomatic lines showed small body size, short life span, progressive muscle atrophy and weakness, as Expression of transgene: Western blot analysis revealed the transgenic protein retained in the stacking well as reduced cage activity, all of which were markedly pronounced and accelerated in the male AR-97Q mice, gel as well as a single band of AR monomer consistent with 97 glutamines and truncated fragments of mutant but not observed or far less severe in the female AR- AR in all symptomatic lines. We detected these proteins Pathology: AR-24Q mice showed no pathologic abnormalities at the age of 12 weeks. In AR-97Q mice, we in the spinal cord, cerebrum, heart, muscle, and pancreas. Although the male AR-97Q mice had more protein detected diffuse nuclear staining and less frequent NIs with 1C2, an antibody specifically recognizing the exwithin the stacking gel than the female AR-97Q mice, the female AR-97Q mice had more monomeric AR protein panded polyQ (Trottier et al., 1995), in the neurons of the spinal cord, cerebrum, cerebellum, brain stem, and ( Figure 1F ). AR-24Q mice showed a single band of AR with 24 glutamines without protein in the stacking gel.
dorsal root ganglia as well as non-neuronal tissue such as the heart, muscle, and pancreas (Table 2 ). In the The nuclear fraction contained the most transgene protein within the stacking gel ( Figure 1G ). neuronal tissues, the nuclei of the motor neurons showed the most prominent diffuse nuclear staining and There was no significant difference in the expression of the mRNA of the transgene between the male and NIs. Glial cells also showed marked staining, but not the dorsal root ganglia. The regions with diffuse nuclear female AR-97Q mice (data not shown). These observations indicate that the nuclear localization is the major staining and NIs also showed immunoreactivity to an antibody to AR (N-20) (data not shown). Neither 1C2 expression profile of the transgene protein in the stacking gel. This nuclear localization was more prominent nor N-20 revealed immunoreactivity in the cytoplasm. Diffuse nuclear staining and NIs were found at 4 weeks in males than in females, while the mRNA expression levels were indistinguishable between genders. of age and became more profound with aging, although significantly prolonged in the castrated male AR-97Q in sham-operated male AR-97Q mice was 27.7 Ϯ 1.2 ng/dl (#7-8, n ϭ 4). mice ( Figure 3D ). The castrated AR-97Q mice showed amelioration of muscle atrophy and body size reduction ( Figure 3E ). In a footprint analysis, the sham-operated Testosterone Administration Deteriorates Phenotypic Expression in Female Tg Mice male AR-97Q mice exhibited motor weakness with dragging of their hindlegs, which improved in the castrated By contrast, testosterone administration markedly exacerbated symptoms, pathologic features, and nuclear lomale AR-97Q mice ( Figure 3F ). In the Western blot analysis using N-20, the mutant AR appearing within the calization of the mutant AR in the female AR-97Q mice. The testosterone-administered female AR-97Q mice stacking gel was markedly diminished in the castrated male AR-97Q mice compared with the sham-operated showed progressive emaciation ( Figure 5A ). The motor impairment assessed by rotarod and cage activity was male AR-97Q mice ( Figure 4A ). The mutant AR in the nuclear fraction also significantly decreased in the cassignificantly worsened in the female AR-97Q mice administered testosterone, being similar to those of the trated male AR-97Q mice ( Figure 4B ). The castrated male AR-97Q mice showed markedly diminished diffuse untreated male AR-97Q mice ( Figures 5B and 5C ). The life span of the female AR-97Q mice was also affected nuclear staining and NIs ( Figure 4C ). These observations suggested that castration markedly prevented nuclear by testosterone administration ( Figure 5D ). The testosterone-administered AR-97Q mice showed marked localization of the mutant AR protein. The serum testosterone in the castrated male AR-97Q mice dramatically muscle atrophy and body size reduction ( Figure 5E ). In a footprint analysis, the testosterone-administered decreased to an undetectable low level, whereas that in other polyQ diseases, the striking therapeutic effects Indeed, lower expression level of mutant AR in female of castration in our Tg mice further suggests that pacarriers due to X inactivation may cause the escape tients with polyQ disease can be rescued by prevention from the manifestation, but our present study also sugof the nuclear translocation of the mutant proteins. We gests that the low level of testosterone prevents the emphasize that it is necessary to investigate hormonenuclear localization of the expressed mutant AR, relike small molecules which alter the nuclear localization sulting in a lack of phenotypic manifestations in the of mutant proteins for therapy of polyQ diseases. female carriers.
A toxic gain of function has been considered the main a Texas Red-labeled primer on 6% denaturing polyacrylamide gel for 12 hr using a 5500 DNA sequencer (Hitachi, Tokyo, Japan).
There have been no substantially effective therapeutic , 1996) . duration on the rod for every mouse. We stopped the timer when the mouse fell from the rod or after an arbitrary limit of 180 s.
The diameter of myelinated fibers in the ventral spinal roots was measured on the transverse sections stained with toluidine blue as We measured cage activity while each mouse was in a transparent acrylic cage (16 ϫ 30 ϫ 14 cm, width ϫ depth ϫ height) housed in described before (Terao et al., 1996) . a soundproofed box. We used an AB system (Neuroscience, Tokyo, Japan) with an infrared ray sensor monitor to measure spontaneous Statistical Analysis motor activity. We automatically totaled and recorded all measureWe analyzed data using the unpaired t test and denoted p values ments for 24 hr per week at 10 min intervals. of 0.05 or less as statistical significance. 
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